- News & Features
Abatacept treatment of PsA in this phase III study showed beneficial trends overall in musculoskeletal manifestations and was well tolerated.
Amid political arguments on both sides of the aisle, three recent studies draw upon data, rather than ideology, to suggest a tie between lack of coverage and negative health results.
The question when the first biologic doesn’t work is: What next?
A CJ blogger feels lucky about catching her rheumatoid arthritis early but starts to fear what RA progression is doing to her body.
People who are controlling their rheumatoid arthritis with an anti-tumor necrosis factor (anti-TNF) drug may get sicker if they switch to a different one, researchers for AbbVie say.
Dr. Laurie urges us not to lose one of our most essential resources: hope.
Kristin gets five unsatisfactory minutes with her doctor and a bill.
This week, Daniel chronicles two weeks in his life -- the life of a patient with rheumatoid arthritis (RA).
Lana explains what role genes have in developing Rheumatoid Arthritis (RA).
Ms. Meniscus is asked about what to do in case there is a Methotrexate shortage.